| Neuraxpharm Switzerland AG - Levetiracetam-Neuraxpharm 250 mg, Filmtabletten | | 69225 | | 01 | | Levetiracetam-Neuraxpharm 250 mg | | Filmtabletten | | N03AX14 | | Levetiracetam | | 30.08.2024 | | |
| | Composition | | levetiracetamum 250 mg, carmellosum natricum conexum corresp. natrium 1.193 mg, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Levetiracetame | 250 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | E 171 | | color. | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 | PR | PR | B | | No |
|
|
